{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:48:30Z","timestamp":1785422910303,"version":"3.56.0"},"reference-count":53,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"The Scientific and Technological Research Council of T\u00fcrkiye","doi-asserted-by":"publisher","award":["124Z505"],"award-info":[{"award-number":["124Z505"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"award":["124Z505"],"award-info":[{"award-number":["124Z505"]}],"id":[{"id":"https:\/\/ror.org\/04w9kkr77","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) remains a major cause of cancer mortality worldwide, highlighting the need for novel molecular targets and alternative therapeutic strategies. TYRO3, a member of the TAM receptor tyrosine kinase family, has been associated with tumor progression and poor prognosis in CRC. In this study, the effects of the natural compounds Meleagrin and Cucurbitacin B on TYRO3 expression and CRC cell behavior were investigated in HCT-116 and HT-29 cells. Cell proliferation, apoptosis, migration, and TYRO3 expression were evaluated using functional and expression-based analyses. Both compounds modulated TYRO3 expression and suppressed proliferation and wound closure dynamics in CRC cells. Cucurbitacin B exerted more pronounced antiproliferative and pro-apoptotic effects, whereas Meleagrin demonstrated antiproliferative activity with comparatively lower effects on normal colon epithelial cells (CCD 841 CoN), suggesting a potentially more favorable selectivity profile. Collectively, these findings support further mechanistic investigation of TYRO3-modulating natural compounds as potential therapeutic candidates for CRC.<\/jats:p>","DOI":"10.3390\/ijms27156759","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:37:00Z","timestamp":1785249420000},"page":"6759","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticancer Effects of Cucurbitacin B and Meleagrin Associated with TYRO3 Downregulation in Colorectal Cancer Cells"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4931-6228","authenticated-orcid":false,"given":"Reha Sertac","family":"Ilhan","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4614-7094","authenticated-orcid":false,"given":"Merve","family":"Gurboga","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgut","family":"Sekerler","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Ulupinar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Ozsavci","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-5639","authenticated-orcid":false,"given":"Ozlem","family":"Bingol Ozakpinar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"ref_1","first-page":"17","article-title":"Cancer Statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer","volume":"27","author":"Cervantes","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal Cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus Molecular Subtypes and the Evolution of Precision Medicine in Colorectal Cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e70041","DOI":"10.1002\/cam4.70041","article-title":"Molecular Subtypes of Colorectal Cancer in the Era of Precision Oncotherapy: Current Inspirations and Future Challenges","volume":"13","author":"Dang","year":"2024","journal-title":"Cancer Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhu, H., Liu, W., Miao, J., Mao, Y., and Li, Q. (2025). Prognostic and Predictive Molecular Biomarkers in Colorectal Cancer. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1532924"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-025-04117-1","article-title":"Consensus Molecular Subtypes (CMS) Classification: A Progress towards Subtype-Driven Treatments in Colorectal Cancer","volume":"24","author":"Kantha","year":"2025","journal-title":"World J. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"a009076","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM Receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-023-02726-w","article-title":"AXL in Cancer: A Modulator of Drug Resistance and Therapeutic Target","volume":"42","author":"Tang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-023-00846-8","article-title":"Therapeutic Targeting of the Functionally Elusive TAM Receptor Family","volume":"23","author":"Miao","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Uribe, D.J., Mandell, E.K., Watson, A., Martinez, J.D., Leighton, J.A., Ghosh, S., and Rothlin, C.V. (2017). The Receptor Tyrosine Kinase AXL Promotes Migration and Invasion in Colorectal Cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179979"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23281","DOI":"10.18632\/oncotarget.3962","article-title":"AXL Is an Oncotarget in Human Colorectal Cancer","volume":"6","author":"Martinelli","year":"2015","journal-title":"Oncotarget"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104005","DOI":"10.1016\/j.drudis.2024.104005","article-title":"AXL Receptor as an Emerging Molecular Target in Colorectal Cancer","volume":"29","author":"Fusco","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.3748\/wjg.v23.i19.3440","article-title":"Role of AXL in Invasion and Drug Resistance of Colon and Breast Cancer Cells and Its Association with P53 Alterations","volume":"23","author":"Nair","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Auyez, A., Sayan, A.E., Kriajevska, M., and Tulchinsky, E. (2021). AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew. Cancers, 13.","DOI":"10.3390\/cancers13194864"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM Receptor Signaling in Immune Homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13091","DOI":"10.1073\/pnas.1302507110","article-title":"Paradoxical Role of the Proto-Oncogene Axl and Mer Receptor Tyrosine Kinases in Colon Cancer","volume":"110","author":"Bosurgi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"56355","DOI":"10.18632\/oncotarget.10889","article-title":"TAM Receptors Tyro3 and Mer as Novel Targets in Colorectal Cancer","volume":"7","author":"Schmitz","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/onc.2016.120","article-title":"Targeting TYRO3 Inhibits Epithelial\u2013Mesenchymal Transition and Increases Drug Sensitivity in Colon Cancer","volume":"35","author":"Chien","year":"2016","journal-title":"Oncogene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"eade3422","DOI":"10.1126\/sciadv.ade3422","article-title":"Targeting BRD3 Eradicates Nuclear TYRO3-Induced Colorectal Cancer Metastasis","volume":"9","author":"Hsu","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_22","first-page":"3035","article-title":"TYRO3 Promotes Tumorigenesis and Drug Resistance in Colorectal Cancer by Enhancing the Epithelial-Mesenchymal Transition Process","volume":"15","author":"Shao","year":"2023","journal-title":"Aging"},{"key":"ref_23","first-page":"2503","article-title":"MicroRNA-7 Inhibits Colorectal Cancer Cell Proliferation, Migration and Invasion via TYRO3 and Phosphoinositide 3-Kinase\/Protein B Kinase\/Mammalian Target of Rapamycin Pathway Suppression","volume":"42","author":"Qin","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00262-024-03879-z","article-title":"Navigating TAM Receptor Dynamics in Tumour Immunotherapy","volume":"74","author":"Yang","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Smart, S.K., Vasileiadi, E., Wang, X., DeRyckere, D., and Graham, D.K. (2018). The Emerging Role of TYRO3 as a Therapeutic Target in Cancer. Cancers, 10.","DOI":"10.3390\/cancers10120474"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kim, H.D., Park, E.J., Choi, E.K., Song, S.Y., Hoe, K.-L., and Kim, D.-U. (2021). G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.730241"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41416-019-0397-6","article-title":"TYRO3 as a Molecular Target for Growth Inhibition and Apoptosis Induction in Bladder Cancer","volume":"120","author":"Dufour","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mikolajczyk, A., Mitula, F., Popiel, D., Kaminska, B., Wieczorek, M., and Pieczykolan, J. (2022). Two-Front War on Cancer\u2014Targeting TAM Receptors in Solid Tumour Therapy. Cancers, 14.","DOI":"10.3390\/cancers14102488"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural Products in Drug Discovery: Advances and Opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural Products as Sources of New Drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhou, L., Zhang, J., Zhao, K., Chen, B., and Sun, Z. (2025). Natural Products Modulating MAPK for CRC Treatment: A Promising Strategy. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1514486"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Vaali-Mohammed, M.-A., Nazar, A., Meeramaideen, M., and Khan, S. (2025). Natural and Synthetic Compounds Against Colorectal Cancer: An Update of Preclinical Studies in Saudi Arabia. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32100546"},{"key":"ref_34","first-page":"1934578X231186206","article-title":"A Literature Review of Meleagrins","volume":"18","author":"Kirsch","year":"2023","journal-title":"Nat. Prod. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bmc.2015.11.038","article-title":"The Indole Alkaloid Meleagrin, from the Olive Tree Endophytic Fungus Penicillium chrysogenum, as a Novel Lead for the Control of c-Met-Dependent Breast Cancer Proliferation, Migration and Invasion","volume":"24","author":"Mady","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"He, X., Jin, Y., Kong, F., Yang, L., Zhu, M., and Wang, Y. (2023). Discovery, Antitumor Activity, and Fermentation Optimization of Roquefortines from Penicillium sp. OUCMDZ-1435. Molecules, 28.","DOI":"10.3390\/molecules28073180"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1186\/s12967-022-03828-3","article-title":"Cucurbitacins as Potential Anticancer Agents: New Insights on Molecular Mechanisms","volume":"20","author":"Varela","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41598-020-57940-9","article-title":"Cucurbitacin B and I Inhibits Colon Cancer Growth by Targeting the Notch Signaling Pathway","volume":"10","author":"Dandawate","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3892\/etm.2023.12183","article-title":"Cucurbitacin B Induces Apoptosis in Colorectal Cells through Reactive Oxygen Species Generation and Endoplasmic Reticulum Stress Pathways","volume":"26","author":"Huang","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"114915","DOI":"10.1016\/j.jep.2021.114915","article-title":"Cucurbitacin B Controls M2 Macrophage Polarization to Suppresses Metastasis via Targeting JAK-2\/STAT3 Signalling Pathway in Colorectal Cancer","volume":"287","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1002\/ptr.70329","article-title":"Mechanism of Cucurbitacin B Targeting ZNF70\/NLRP3 Axis Against Inflammation-Associated Colorectal Cancer","volume":"40","author":"Cao","year":"2026","journal-title":"Phytother. Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yin, D., Chen, H., Lin, S., Sun, Y., Jing, X., Chang, R., Feng, Y., Dong, X., Qu, C., and Ni, J. (2025). Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26168003"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hsu, K.-C., Chen, Y.-F., Lin, S.-R., and Yang, J.-M. (2011). iGEMDOCK: A Graphical Environment of Enhancing GEMDOCK Using Pharmacological Interactions and Post-Screening Analysis. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-S1-S33"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: An Open-Source Tool for Atom Mapping and RMSD Calculation of Symmetric Molecules through Graph Isomorphism","volume":"11","author":"Bell","year":"2019","journal-title":"J. Cheminform."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1080\/07391102.2023.2209193","article-title":"DFT, Molecular Docking and Molecular Dynamics Simulation Studies on Some Recent Natural Products Revealing Their EGFR Tyrosine Kinase Inhibition Potential","volume":"42","author":"Erdogan","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1007\/s00210-025-04273-x","article-title":"Exploring the Antitumor Potential of Cucurbitacin B in Hepatocellular Carcinoma through Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations","volume":"398","author":"Zhang","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12935-020-01519-x","article-title":"circRAE1 Promotes Colorectal Cancer Cell Migration and Invasion by Modulating miR-338-3p\/TYRO3 Axis","volume":"20","author":"Du","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_50","first-page":"101263","article-title":"The First Laminin G-like Domain of Protein S Is Essential for Binding and Activation of Tyro3 Receptor and Intracellular Signalling","volume":"30","author":"Chaput","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_51","unstructured":"Karakulak, T. (2019). Molecular Specificity of Tam Family Receptors Towards Different Ligands. [Master\u2019s Thesis, Dokuz Eylul University]."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.24198\/ijcb.v2i1.46322","article-title":"Molecular Interaction Analysis and Visualization of Protein-Ligand Docking Using Biovia Discovery Studio Visualizer","volume":"2","author":"Baroroh","year":"2023","journal-title":"IJCB"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A Critical Assessment of Docking Programs and Scoring Functions","volume":"49","author":"Warren","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6759\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:26:19Z","timestamp":1785385579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":53,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156759"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156759","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}